[出典] "Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy" Shu R [..] Trounson A. Bioeng Transl Med. 2023-07-10. https://doi.org/10.1002/btm2.10571 [著者所属] Monash U, ToolGen Inc,  癌免疫療 ... もっと読む